http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Genomic Health to Present at the 35th Annual J.P. Morgan Healthcare Conference
-
Genomic Health Announces Inclusion of Oncotype DX® in the 8th Edition of American Joint Committee on Cancer (AJCC) Criteria for Breast Cancer Staging
-
Genomic Health (GHDX) Reports Results from Multiple Oncotype DX Studies
-
Genomic Health Announces Results from Multiple Oncotype DX® Studies, Reinforcing its Impact in Delivering Precision Medicine to Breast Cancer Patients Around the World
-
Genomic Health Announces Presentation of Multiple Oncotype DX® Studies at the 2016 CTRC-AACR San Antonio Breast Cancer Symposium, Reinforcing Value of Genomics in Precision Medicine
-
Genomic Health to Present at the Credit Suisse 25th Annual Healthcare Conference
-
Genomic Health Reports Third Consecutive Quarter of Double-Digit Revenue Growth in Announcement of Third Quarter 2016 Financial Results
-
Genomic Health Announces Positive Topline Clinical Validation Study Results Demonstrating Oncotype DX® Prostate Cancer Test Predicts Risk of Metastasis and Mortality
-
Comprehensive Economic Analysis Published in Reviews in Urology Demonstrates Oncotype DX® Prostate Cancer Test Leads to Substantial Cost Savings and Increase in Active Surveillance
-
Genomic Health to Announce Third Quarter 2016 Financial Results and Host Conference Call on Tuesday, November 1, 2016
-
Genomic Health (GHDX) Announces Results from Oncotype SEQ Liquid Select Validation Study
-
Genomic Health Presents Robust Analytical Validation Study Results of Oncotype SEQ™ Liquid Biopsy Mutation Panel
-
Multiple Oncotype DX® Presentations at ESMO 2016 Congress Reinforce Its Unique Clinical Utility with Prospective Outcomes Results in Over 63,000 Breast Cancer Patients
-
Genomic Health Reinforces Global Leadership in Genomic-based Diagnostics with Presentation of Nine Personalized Medicine Studies Conducted in Six Countries at ESMO 2016 Congress
-
Genomic Health to Present at the 2016 Wells Fargo Healthcare Conference
-
Genomic Health to Present at the 2016 Wells Fargo Healthcare Conference
-
Genomic Health Reports Continued Double-Digit Growth in Announcement of Second Quarter 2016 Financial Results, Raises Low End of Full-Year Test and Revenue Guidance
-
Genomic Health to Announce Second Quarter 2016 Financial Results and Host Conference Call on Tuesday, August 2, 2016
-
Genomic Health and Epic Sciences Announce Strategic Collaboration to Deliver Novel AR-V7 Liquid Biopsy Test to Predict Treatment Response in Metastatic Prostate Cancer
-
Genomic Health Launches Oncotype SEQ™ Liquid Biopsy Mutation Panel
-
Genomic Health (GHDX) Announces Publication of Results from NCI Surveillance, Epidemiology, and End Results Registry
-
Nature Partner Journals Publish Five-year Outcomes Results from SEER Registry Demonstrating Oncotype DX® Accurately Identifies Early-stage Breast Cancer Patients with Excellent Survival
-
Genomic Health Announces Multiple Oncotype DX® Presentations at ASCO 2016 Showcasing Industry-leading Commitment to Bringing Precision Medicine to Cancer Patients
-
Genomic Health to Present at Jefferies 2016 Healthcare Conference
-
Genomic Health (GHDX) to Present Additional Oncotype DX Data at ASCO 2016
-
Genomic Health Announces Presentation of Seven Oncotype DX® Studies at the 2016 American Society of Clinical Oncology Annual Meeting, Including Additional Prospective Outcomes Analysis
-
Genomic Health (GHDX) Announces Publication of Positive Oncotype DX Data in ASCO Journal
-
Genomic Health Announces Publication in Journal of Clinical Oncology Demonstrating Oncotype DX® Predicts Late Distant Recurrence in Breast Cancer
-
Genomic Health Reports Double-Digit Revenue and Test Growth in Announcement of First Quarter 2016 Financial Results
-
Genomic Health to Present at Bank of America Merrill Lynch 2016 Health Care Conference
-
Genomic Health to Announce First Quarter 2016 Financial Results and Host Conference Call on Wednesday, May 4, 2016
-
Genomic Health (GHDX) Announces Five-Year PlanB Study Data; Results Consistent with TAILORx Conclusion
-
Genomic Health Announces Five-year Outcomes from International 'PlanB' Study Demonstrating the Clinical Utility of Oncotype DX® in Node-positive and High-risk Node-negative Breast Cancer
-
German National Cancer Guidelines Distinguish Oncotype DX® as First and Only Multi-gene Breast Cancer Test with 1A Level of Evidence
-
Genomic Health to Present at the Cowen and Company 36th Annual Health Care Conference
-
Journal of Clinical Oncology Publishes Prospective Outcomes Results from Large International Trial Using Oncotype DX®
-
Genomic Health Announces 2016 Financial Outlook and Provides 2015 Fourth Quarter and Year-End Financial Results
-
Trading Radar for 2/10: Twitter (TWTR), Time Warner (TWX), Tesla (TSLA), Cisco (CSCO), Humana (HUM) Report
-
Genomic Health to Announce Fourth Quarter and Year-End 2015 Financial Results and Host Conference Call on Wednesday, February 10, 2016
-
Genomic Health (GHDX) Plans Oncotype SEQ Launch for mid-2016
-
Genomic Health Announces Plans to Launch Liquid Biopsy Mutation Panel in 2016
-
Genomic Health (GHDX) Prelim. Q4, FY15 Revenues Miss Expectations
-
Genomic Health Announces Preliminary 2015 Revenue and Confirms 2016 Growth Expectations
-
Genomic Health to Present at the 34th Annual J.P. Morgan Healthcare Conference
-
Genomic Health (GHDX) Announces Results from Multiple Oncotype DX Breast Cancer Test Studies at SABCS
-
New "Big Data" Brings Total Number of Breast Cancer Patients Studied to 50,000, Demonstrating Oncotype DX® Accurately Predicts Clinical Outcomes
-
Genomic Health Announces Presentation of Eight Oncotype DX® Studies at the 2015 CTRC-AACR San Antonio Breast Cancer Symposium
-
CMS Releases Final 2016 Clinical Lab Fee Schedule (CLFS) Including Gap-fill Pricing for Oncotype DX® Colon Cancer Test
-
Genomic Health Announces Presentation of Eight Oncotype DX® Studies at the 2015 CTRC-AACR San Antonio Breast Cancer Symposium
-
Genomic Health Reports Highest Test Growth in Two Years in Announcement of Third Quarter 2015 Financial Results

